Le Lézard5d
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray
EYSINS, Switzerland, Feb. 10, 2025 /PRNewswire/ -- AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® Celiac ...
manilatimes2d
Porsche and RM Sotheby's to auction rare 911 S/T to support the American Red Cross
Porsche and RM Sotheby's to auction rare 911 S/T to support the American Red Cross ...
Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex®
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...
BIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CONTINUED SUPPORT FROM CF AMR SYNDICATE
About the Cystic Fibrosis Trust Cystic Fibrosis Trust is the only UK-wide charity dedicated to uniting for a life unlimited for everyone affected by cystic fibrosis. The Trust funds cutting edge ...
High altitude and hard falls: How I mastered skiing at 40
As Warren explains, the key to having full control over your skiing is to press your shins against the front of the ski boot ...
Six million people could die from HIV and AIDS if US funding stops, UN agency warns
GENEVA -- More than six million people could die from HIV and AIDS in the next four years if U.S. President Donald Trump's ...
Hosted on MSN15h
Nestlé sales beat forecast after price hikes
Swiss food giant Nestlé reported better-than-expected annual sales on Thursday, boosting its shares after the maker of ...
Unlocking hospitality Potential: Sommet Education Business Solutions Revamps talent development models
With rapid technological advancements reshaping industries, the World Economic Forum's Future of Jobs Report 2024 predicts ...
Moderna posts bigger loss than expected as it scales down manufacturing
Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down manufacturing amid weakening demand for its COVID-19 vaccine. The ...